Letter in reply: more power to ivermectin multidrug therapy

Future Microbiol. 2022 Nov:17:1283-1285. doi: 10.2217/fmb-2022-0184. Epub 2022 Sep 22.
No abstract available

Keywords: COVID; SARS-CoV-2; combination therapy; doxycycline; ivermectin; multidrug therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19*
  • Drug Therapy, Combination
  • Humans
  • Ivermectin* / therapeutic use
  • Leprostatic Agents / therapeutic use
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • Leprostatic Agents
  • Ivermectin